Effectiveness and Safety of Low-Sodium Oxybate in Participants with Narcolepsy: Primary Results from the DUET Study
Abstract Introduction A phase 4, prospective, open-label study of low-sodium oxybate (LXB) in narcolepsy (type 1 [NT1] or 2 [NT2]) or idiopathic hypersomnia included novel symptom outcomes important to patients (Jazz DUET; NCT05875974; registered 16 May 2023). Primary results from the narcolepsy coh...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Adis, Springer Healthcare
2026-04-01
|
| Seri Bilgileri: | Neurology and Therapy |
| Konular: | |
| Online Erişim: | https://doi.org/10.1007/s40120-026-00921-3 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|
